{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:04:24Z","timestamp":1780340664043,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.drugalcdep.2017.12.040","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T13:26:13Z","timestamp":1519997173000},"page":"171-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder"],"prefix":"10.1016","volume":"186","author":[{"given":"Stephen R.","family":"Holt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Donroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4177-1859","authenticated-orcid":false,"given":"Dana A.","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-9213","authenticated-orcid":false,"given":"Jeanette M.","family":"Tetrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0005","series-title":"Drug Testing: A White Paper of the American Society of Addiction Medicine","author":"American Society of Addiction Medicine","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/pubmed\/fdi031","article-title":"Mode of questionnaire administration can have serious effects on data quality","volume":"27","author":"Bowling","year":"2005","journal-title":"J. Public Health (Oxf.)"},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0015","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1037\/0022-3514.70.5.979","article-title":"Lying in everyday life","volume":"70","author":"DePaulo","year":"1996","journal-title":"J. Per. Soc. Psychol."},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1542\/peds.2009-3059","article-title":"Just say I Don't: lack of concordance between teen report and biological measures of drug use","volume":"126","author":"Delaney-Black","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugalcdep.2017.07.040","article-title":"Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice","volume":"80","author":"Donroe","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/00952999309001632","article-title":"Self-reported drug use data: what do they reveal?","volume":"19","author":"Harrison","year":"1993","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/10826089409047909","article-title":"Radioimmunoassay of hair for determination of cocaine, heroin, and marijuana exposure: comparison with self-report","volume":"29","author":"Hindin","year":"1994","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0040","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jat\/32.7.516","article-title":"Urinary buprenorphine concentrations in patients treated with suboxone as determined by liquid chromatography-mass spectrometry and CEDIA immunoassay","volume":"32","author":"Hull","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/ADM.0000000000000146","article-title":"A survey of ASAM members' knowledge, attitudes, and practices in urine drug testing","volume":"9","author":"Kirsh","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/ADM.0000000000000029","article-title":"Buprenorphine diversion and misuse in outpatient practicet","volume":"8","author":"Lofwall","year":"2014","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0055","series-title":"Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviors","author":"Marlatt","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/02791072.2015.1014948","article-title":"Changes in quality of life following buprenorphine treatment: relationship with treatment retention and illicit opioid use","volume":"47","author":"Mitchell","year":"2015","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0065","first-page":"45","article-title":"Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy","volume":"11","author":"Morasco","year":"2015","journal-title":"J. Opioid. Manag."},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0070","series-title":"Clinical Drug Testing in Primary Care. Technical Assistance Publication (TAP) 32. HHS Publication No. (SMA) 12\u20134668","author":"Substance Abuse and Mental Health Services Administration","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1521-0391.2014.12087.x","article-title":"Differential diagnosis for a stable patient maintained on buprenorphine who gives a urine toxicology screen negative for buprenorphine","volume":"23","author":"Sethi","year":"2014","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3122\/jabfm.2014.05.140107","article-title":"Deception for drugs: self-reported doctor shopping among young adults","volume":"27","author":"Stogner","year":"2014","journal-title":"J. Am. Board Fam. Med."},{"key":"10.1016\/j.drugalcdep.2017.12.040_bib0085","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/08897077.2017.1356796","article-title":"Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment","volume":"38","author":"Suzuki","year":"2017","journal-title":"Subst. Abus."}],"updated-by":[{"DOI":"10.1016\/j.drugalcdep.2019.107601","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000}}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618301054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618301054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T13:50:41Z","timestamp":1535032241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618301054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":17,"alternative-id":["S0376871618301054"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.12.040","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.drugalcdep.2019.107601","asserted-by":"object"}]},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}